Development of New Strategies for Malaria Chemoprophylaxis: From Monoclonal Antibodies to Long-Acting Injectable Drugs

Drug discovery for malaria has traditionally focused on orally available drugs that kill the abundant, parasitic blood stage. Recently, there has also been an interest in injectable medicines, in the form of monoclonal antibodies (mAbs) with long-lasting plasma half-lives or long-lasting depot formu...

Descripción completa

Detalles Bibliográficos
Autor principal: Moehrle, Joerg J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024890/
https://www.ncbi.nlm.nih.gov/pubmed/35448833
http://dx.doi.org/10.3390/tropicalmed7040058

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024890/
https://www.ncbi.nlm.nih.gov/pubmed/35448833
http://dx.doi.org/10.3390/tropicalmed7040058

Ejemplares similares